NEW YORK (GenomeWeb) – New England Biolabs and TTP have established a non-exclusive partnership to offer services to molecular diagnostic technology developers.
Together, Ipswich, Massachusetts-based NEB and Cambridge, UK-based TTP will offer product-development services spanning instrumentation, consumables, and reagents.
More specifically, the partnership is focused on supporting customers in the MDx and wider life science space to "rapidly transition ideas into commercially successful products," the partners said.
The services will couple NEB's catalog of reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and physical engineering know-how.
"At TTP, we understand the fundamental steps required to convert lab-based biological processes to a functional low-cost disposable and instrument, and together we are now able to fast track more complete product development solutions," Giles Sanders, consultant at TTP, said in a statement.
"NEB was already committed to developing novel enzyme specificities for incorporation into new clinical and molecular testing platforms," Breton Hornblower, product manager at NEB, said in a statement. "Our customers will now be able to access these reagents as part of these services, along with those of TTP."